Page last updated: 2024-08-03 00:26:35

carbocyclic 3-deazaadenosine

Description

carbocyclic 3-deazaadenosine: carboxylic analog of 3-deazaadenosine [MeSH]

Cross-References

ID SourceID
PubMed CID13145979
SCHEMBL ID11193735
MeSH IDM0105245

Synonyms (2)

Synonym
carbocyclic 3-deazaadenosine
SCHEMBL11193735

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (61.54)18.7374
1990's3 (23.08)18.2507
2000's2 (15.38)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (6.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (93.33%)84.16%
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
adenine6-aminopurines;
purine nucleobase
Daphnia magna metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1985198837.2low050000
thymidinepyrimidine 2'-deoxyribonucleosideEscherichia coli metabolite;
human metabolite;
metabolite;
mouse metabolite
1987198737.0low010000
alaninealanine zwitterion;
alanine;
L-alpha-amino acid;
proteinogenic amino acid;
pyruvate family amino acid
EC 4.3.1.15 (diaminopropionate ammonia-lyase) inhibitor;
fundamental metabolite
1988198836.0low010000
methionineaspartate family amino acid;
L-alpha-amino acid;
methionine zwitterion;
methionine;
proteinogenic amino acid
antidote to paracetamol poisoning;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical
1988198836.0low010000
cytidinecytidinesEscherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
1986199036.0low011000
tubercidinantibiotic antifungal agent;
N-glycosylpyrrolopyrimidine;
ribonucleoside
antimetabolite;
antineoplastic agent;
bacterial metabolite
1982200134.1high084100
vidarabinebeta-D-arabinoside;
purine nucleoside
antineoplastic agent;
bacterial metabolite;
nucleoside antibiotic
1986198638.0low010000
3-deazaadenosine1988198836.0low010000
coformycincoformycinsEC 3.5.4.4 (adenosine deaminase) inhibitor1988198836.0low010000
zidovudineazide;
pyrimidine 2',3'-dideoxyribonucleoside
antimetabolite;
antiviral drug;
HIV-1 reverse transcriptase inhibitor
1987198737.0low010000
ribavirin1-ribosyltriazole;
aromatic amide;
monocarboxylic acid amide;
primary carboxamide
anticoronaviral agent;
antiinfective agent;
antimetabolite;
antiviral agent;
EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor
1986199036.3low021000
adefovir6-aminopurines;
ether;
phosphonic acids
antiviral drug;
DNA synthesis inhibitor;
drug metabolite;
HIV-1 reverse transcriptase inhibitor;
nephrotoxic agent
1987198737.0low010000
adenosineadenosines;
purines D-ribonucleoside
analgesic;
anti-arrhythmia drug;
fundamental metabolite;
human metabolite;
vasodilator agent
1985200034.8low041000
aristeromycin1987198737.0low010000
neplanocin a1985198837.5low040000
3-deazaneplanocin1987200030.5low011000
9-(2,3-dihydroxypropyl)adenine1985198837.5medium040000
organophosphonatesdivalent inorganic anion;
phosphite ion
1987198737.0low010000
3-deazaadenine1988198836.0low010000
s-adenosylhomocysteineadenosines;
amino acid zwitterion;
homocysteine derivative;
homocysteines;
organic sulfide
cofactor;
EC 2.1.1.72 [site-specific DNA-methyltransferase (adenine-specific)] inhibitor;
EC 2.1.1.79 (cyclopropane-fatty-acyl-phospholipid synthase) inhibitor;
epitope;
fundamental metabolite
2000200024.0low001000
carbodine1986199036.0medium011000
riboseD-ribose;
ribopyranose
1986198737.5low020000
adenosine kinase1988198836.0low010000
s-adenosylmethionineorganic cation;
sulfonium compound
coenzyme;
cofactor;
human metabolite;
micronutrient;
Mycoplasma genitalium metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
1988198836.0low010000
hypoxanthinenucleobase analogue;
oxopurine;
purine nucleobase
fundamental metabolite1988198836.0low010000
alanosine1988198836.0low010000
pyrazofurinC-glycosyl compound;
pyrazoles
antimetabolite;
antimicrobial agent;
antineoplastic agent;
EC 4.1.1.23 (orotidine-5'-phosphate decarboxylase) inhibitor
1986198737.5low020000
ConditionIndicatedStudiesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
Disease Models, Animal01999199925.0medium001000
Ebola Hemorrhagic Fever01999200024.5high002000
Hemorrhagic Fever, Ebola01999200024.5high002000
Viral Diseases01983198341.0medium010000
Virus Diseases01983198341.0medium010000

Safety/Toxicity (1)

ArticleYear
Evaluation of the toxicity and antiviral activity of carbocyclic 3-deazaadenosine against respiratory syncytial and parainfluenza type 3 viruses in tissue culture and in cotton rats.
Antiviral research, , Volume: 14, Issue:4-5

Pharmacokinetics (1)

ArticleYear
Pharmacokinetics of the antiviral agent carbocyclic 3-deazaadenosine.
Drug metabolism and disposition: the biological fate of chemicals, , Volume: 21, Issue:4

Dosage (2)

ArticleYear
Intracellular phosphorylation of carbocyclic 3-deazaadenosine, an anti-Ebola virus agent.
Antiviral chemistry & chemotherapy, , Volume: 12, Issue:4
2001
Pharmacokinetics of the antiviral agent carbocyclic 3-deazaadenosine.
Drug metabolism and disposition: the biological fate of chemicals, , Volume: 21, Issue:4